That really is not related to anything I typed. If you are going to defend our government for how they handled this whole pandemic as well as securing vaccines, then don't bother replying. I'm tired of hearing it.
It's been hashed out a lot. The answer is, bad idea. Go with what those who actually made the vaccine say. Stop trying for the "easy answer" because it will burn you in the end. (generic you)
Yes, but statistically with only Phase 3 data we cannot have high confidence about serious disease effectiveness compared to non-serious. They originally wanted 60 cases or so of covid in study. Not 60 serious cases. Normally how many cases of serious cases per non serious are there? How much variance is possible given that sample size?
Yes, the quicker we fully vaccinate the quicker it is over. We should not vaccinate single doses though when it is supposed to be a 2 shot deal. What J&J does with 2 doses is something we'll find out in the future.
Oh I agree, follow the recommended dosing schedule.
10 million doses is 10 million Americans vaccinated. That’s more then entire state of Michigan.
There are 21 million of us here in FL. Trying to guess at what my number in line is...
They had a board member already confirm they are on track for deliveries worldwide and would have 100M doses delivered in the US this Spring, as early as end of April. On their earnings call the CFO also confirmed they would meet the targets for sales including the 100M to the US. It’s going to take a few weeks for EUA so probably won’t see significant doses delivered until March. They have a whole month to build supply. they won’t have 100M doses to deliver on March 1 but they should be ramped up to deliver 5 to 10M doses a week and that should get them done before the end of June and maybe a lot sooner.
That’s 10 million immediately plus an additional number each week as they deliver more.
This will help immensely. Having testing as good as that would be very helpful
Half received placebo.
www.pfizer.com
Half received placebo.
approx 72000 trial participants is just Pfizer and Moderna studies.
you need to look at the number of serious cases. Because the vaccine is so effective the number of covid cases is real low (8 or so in the Pfizer study). So what ratio are normal per any case of covid. If less than 1 in 10 ( approx) you would see no cases in the vaccinated 9 cases of covid on average. The study does not have enough data to say that the vaccine protects especially well against serious vs non serious covid.
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine | Pfizer
Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and demonstrated 95% efficacy in preventing COVID-19 in those without prior infection 7 days or more after the second dose Vaccine efficacy...
Ahh. My mistake. I thought you were stating total participants.
I know of companies that will only start to consider return to office in July
